FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1787716617> ?p ?o ?g. }

• W1787716617 endingPage "900" @default.
• W1787716617 startingPage "1895" @default.
• W1787716617 abstract "Flt3-ligand (Flt3-L) is an early acting costimulatory cytokine that has been shown to possess antitumor properties in murine solid tumor models. Flt3-L is a trans-membrane protein (tm) but can be proteolytically cleaved to a soluble form, which is also biologically active. In this study, the antitumor effect of both soluble and tmFlt3-L was evaluated in a mouse leukemia model. To mimic the multiorgan involvement characteristic of human leukemia, a factor-dependent cell line FDC.P1 was made leukemogenic by transfection with the human BCR/ABL gene. The resulting cell line, AW, expresses BCR/ABL RNA and protein. It maintains a similar in vitro growth rate as the parent cell line, but unlike the parent cell line, AW cells are factor independent and tumorigenic. Growth of FDC.P1 and AW cells are unaffected by the addition of soluble human Flt3-L to the culture medium. Also, AW growth is unaltered after transduction with a retroviral vector expressing the tm isoform of human Flt3-L (AW/tmFlt3-L). When 10(5) AW cells were i.v. injected into syngeneic DBA/2 mice, fatal leukemia developed in nine of nine (100%) mice within 4-6 weeks with involvement of the blood, bone marrow, spleen, and thymus. Systematic administration of soluble human Flt3-L (500 microg/kg/day) for 10 days protected mice from leukemia, with 11 of 17 mice tumor free at week 8 (64.7%) The tm isoform of Flt3-L also was protective. When 10(4) AW/tmFlt3-L cells were injected i.v. into mice, only 35.7% (5 of 14) developed leukemia versus 100% in control groups. Adoptive transfer of immunity was also demonstrated; T cells obtained from tumor-free animals conferred protection to 87% (seven of eight) naive mice challenged with AW cells. These results demonstrate that both soluble and membrane-bound human Flt3-L has antitumor activity in this leukemia model." @default.
• W1787716617 created "2016-06-24" @default.
• W1787716617 creator A5033600849 @default.
• W1787716617 creator A5052069729 @default.
• W1787716617 creator A5063687138 @default.
• W1787716617 creator A5085881359 @default.
• W1787716617 date "2000-04-01" @default.
• W1787716617 modified "2023-09-26" @default.
• W1787716617 title "Antileukemic activity of Flt3 ligand in murine leukemia." @default.
• W1787716617 cites W129878118 @default.
• W1787716617 cites W134922517 @default.
• W1787716617 cites W1488558875 @default.
• W1787716617 cites W1489777708 @default.
• W1787716617 cites W1497008980 @default.
• W1787716617 cites W1505013360 @default.
• W1787716617 cites W1514412416 @default.
• W1787716617 cites W154795380 @default.
• W1787716617 cites W1560416396 @default.
• W1787716617 cites W1605948149 @default.
• W1787716617 cites W1608356737 @default.
• W1787716617 cites W1662416542 @default.
• W1787716617 cites W1699876868 @default.
• W1787716617 cites W1822927306 @default.
• W1787716617 cites W1971833736 @default.
• W1787716617 cites W1982920370 @default.
• W1787716617 cites W1990668606 @default.
• W1787716617 cites W1991148746 @default.
• W1787716617 cites W2022262230 @default.
• W1787716617 cites W2031295699 @default.
• W1787716617 cites W2050502992 @default.
• W1787716617 cites W2071432029 @default.
• W1787716617 cites W2076372887 @default.
• W1787716617 cites W2084390253 @default.
• W1787716617 cites W2085397716 @default.
• W1787716617 cites W2087460262 @default.
• W1787716617 cites W2106883237 @default.
• W1787716617 cites W2128330870 @default.
• W1787716617 cites W2156831625 @default.
• W1787716617 cites W2170748847 @default.
• W1787716617 cites W2254640582 @default.
• W1787716617 cites W2279485973 @default.
• W1787716617 cites W2280729002 @default.
• W1787716617 cites W232742645 @default.
• W1787716617 cites W2337362637 @default.
• W1787716617 cites W2339666810 @default.
• W1787716617 cites W2409089508 @default.
• W1787716617 cites W2411171890 @default.
• W1787716617 cites W2412963611 @default.
• W1787716617 cites W2415023929 @default.
• W1787716617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10766177" @default.
• W1787716617 hasPublicationYear "2000" @default.
• W1787716617 type Work @default.
• W1787716617 sameAs 1787716617 @default.
• W1787716617 citedByCount "7" @default.
• W1787716617 crossrefType "journal-article" @default.
• W1787716617 hasAuthorship W1787716617A5033600849 @default.
• W1787716617 hasAuthorship W1787716617A5052069729 @default.
• W1787716617 hasAuthorship W1787716617A5063687138 @default.
• W1787716617 hasAuthorship W1787716617A5085881359 @default.
• W1787716617 hasConcept C153911025 @default.
• W1787716617 hasConcept C185592680 @default.
• W1787716617 hasConcept C203014093 @default.
• W1787716617 hasConcept C2778461978 @default.
• W1787716617 hasConcept C2778690821 @default.
• W1787716617 hasConcept C2780007613 @default.
• W1787716617 hasConcept C2780931953 @default.
• W1787716617 hasConcept C502942594 @default.
• W1787716617 hasConcept C54355233 @default.
• W1787716617 hasConcept C55493867 @default.
• W1787716617 hasConcept C62112901 @default.
• W1787716617 hasConcept C81885089 @default.
• W1787716617 hasConcept C86803240 @default.
• W1787716617 hasConceptScore W1787716617C153911025 @default.
• W1787716617 hasConceptScore W1787716617C185592680 @default.
• W1787716617 hasConceptScore W1787716617C203014093 @default.
• W1787716617 hasConceptScore W1787716617C2778461978 @default.
• W1787716617 hasConceptScore W1787716617C2778690821 @default.
• W1787716617 hasConceptScore W1787716617C2780007613 @default.
• W1787716617 hasConceptScore W1787716617C2780931953 @default.
• W1787716617 hasConceptScore W1787716617C502942594 @default.
• W1787716617 hasConceptScore W1787716617C54355233 @default.
• W1787716617 hasConceptScore W1787716617C55493867 @default.
• W1787716617 hasConceptScore W1787716617C62112901 @default.
• W1787716617 hasConceptScore W1787716617C81885089 @default.
• W1787716617 hasConceptScore W1787716617C86803240 @default.
• W1787716617 hasIssue "7" @default.
• W1787716617 hasLocation W17877166171 @default.
• W1787716617 hasOpenAccess W1787716617 @default.
• W1787716617 hasPrimaryLocation W17877166171 @default.
• W1787716617 hasRelatedWork W1991797776 @default.
• W1787716617 hasRelatedWork W2353119352 @default.
• W1787716617 hasRelatedWork W2357329258 @default.
• W1787716617 hasRelatedWork W2357577818 @default.
• W1787716617 hasRelatedWork W2368704008 @default.
• W1787716617 hasRelatedWork W2375687892 @default.
• W1787716617 hasRelatedWork W2381960704 @default.
• W1787716617 hasRelatedWork W2388714568 @default.
• W1787716617 hasRelatedWork W2399920194 @default.

• next